Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
September 09, 2022 at 11:49 AM EDT
This week's local life sciences industry news includes details on a Philadelphia biotech company achieving an FDA first, a gift that will expand treatment options at a local ALS center, and more.
